24/7 Patient Assistance: 760-405-8205

Anthony El-Khoueiry, MD

Medical Oncologist

Write a review
Doctor's profile photo

Request a call back

Conditions Treated Laryngeal Cancer Lung Cancer Ovarian Cancer Pericardial Mesothelioma Peritoneal Mesothelioma Pleural Mesothelioma Testicular Mesothelioma

  • Bio & Insurance Information

    Dr. Anthony El-Khoueiry is a medical oncology specialist in Los Angeles, California and he works at several hospitals in the area, such as Keck Medical Center of USC and USC Norris Cancer Hospital. He got his diploma from Keck School of Medicine of USC and did his residency in Internal Medicine at the University of Southern California - LAC+USC Medical Center. Dr. Anthony El-Khoueiry also completed three fellowships in Hematology and Medical Oncology at the University of Southern California - LAC+USC Medical Center. The doctor has an experience of more than 20 years.



  • Education & Training

    dept_icon

    Keck of USC

    Medical School

    dept_icon

    University of Southern California - LAC+USC Medical Center

    Residency

    dept_icon

    University of Southern California - LAC+USC Medical Center

    Fellowship

  • Board Certifications

    American Board of Internal Medicine - Oncology

  • Hospital & Practice

    Keck Hospital of USC - Medical Center

    Languages: English/Spanish

    (323) 442-8500

    1500 San Pablo St

    Los Angeles, California 90033

    Read More

    USC Norris Comprehensive Cancer Center

    Languages: English/Spanish

    (323) 865-3000

    1441 Eastlake Avenue

    Los Angeles, California 90033

    Read More
  • Publications & Memberships

    Dr. Anthony El-Khoueiry has contributed to 3 publications.

    Clinical relevance of EMT and stem-like gene expression in circulating tumor cells of metastatic colorectal cancer patients.

    Ning Y, Zhang W, Hanna DL, Yang D, Okazaki S, Berger MD, Miyamoto Y, Suenaga M, Schirripa M, El-Khoueiry A, Lenz H; Pharmacogenomics J.. 2016-08-09.

    See more >>

    A Phase I Study of the Safety, Pharmacokinetics, and Pharmacodynamics of Combination Therapy with Refametinib plus Sorafenib in Patients with Advanced Cancer.

    Adjei AA, Richards DA, El-Khoueiry A, Braiteh F, Becerra CHR, Stephenson JJ, Hezel AF, Sherman M, Garbo L, Leffingwell DP, Iverson C, Miner JN, Shen Z, Yeh L, Gunawan ...; Clin. Cancer Res.. 2016-05-15.

    See more >>

    Guadecitabine (SGI-110) priming sensitizes hepatocellular carcinoma cells to oxaliplatin.

    Kuang, Y.,El-Khoueiry, A.,Taverna, P.,Ljungman, M.,Neamati, N.; Mol Oncol. 2015 Jul 15.

    See more >>

    Memberships

    American Society of Clinical Oncology